Bulletin
Investor Alert

New York Markets Close in:

Topics

Centers for Disease Control and Prevention

Video

As Kids' Covid-19 Vaccine Nears, Doctors Work to Ease Parent Concerns

  • As Kids' Covid-19 Vaccine Nears, Doctors Work to Ease Parent Concerns As Kids' Covid-19 Vaccine Nears, Doctors Work to Ease Parent Concerns 5:53
    Fully Vaccinated People Don't Need Masks in Most Settings, CDC Says Fully Vaccinated People Don't Need Masks in Most Settings, CDC Says 1:43
    WSJ Opinion: Teachers Unions, Public Schools and That 'Covid' Relief Bill WSJ Opinion: Teachers Unions, Public Schools and That 'Covid' Relief Bill 4:14
    Moderna Delivers Covid-19 Shots, Boosts Vaccination Campaign Moderna Delivers Covid-19 Shots, Boosts Vaccination Campaign 1:52
7:49 a.m. Today - By Ciara Linnane
U.S. moves closer to vaccinating young children, and WHO warns pandemic is 'far from finished'In positive news for parents, a U.S. Food and Drug Administration advisory committee voted 17-0 in favor of vaccinating children aged 5 to 11 with the shots developed by Pfizer and BioNTech. agreeing that the benefits outweigh the risks in that age group.
5:23 a.m. Today - By Andrew Keshner
Unvaccinated? Here's why you could be paying more for health care costs soonSomething to consider this open enrollment season: Your vaccination status can have financial consequences
5:07 a.m. Today - By Elisabeth Buchwald
Kids under 12 could soon get COVID-19 vaccinations — 5 key questions parents should ask'Most children will not have symptoms severe enough that they need to miss school,' said Dr. Nipunie Rajapakse, a pediatric infectious disease specialist with the Mayo Clinic Children’s Center.
4:19 a.m. Today - By Jaimy Lee
FDA advisors recommend BioNTech and Pfizer's COVID-19 shot for childrenA group of scientists who advise the Food and Drug Administration said the benefits of BioNTech and Pfizer's COVID-19 vaccine outweigh the risks for children between the ages of 5 and 11.
2:42 a.m. Today - Barrons.com
Twitter and Alphabet Bat Away Fears Over Apple’s Privacy Setting Democrats scramble for ways to fund social spending and climate bill, FDA advisors recommend Covid-19 vaccines for children 5 to 11, China Telecom banned from U.S. market, and other news to start your day.
2:28 a.m. Today - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 244.6 million and FDA advisors back Pfizer's COVID-19 shot for childrenThe global tally for the coronavirus-borne illness climbed above 244.6 million on Wednesday, while the death toll edged above 4.96 million, according to . The U.S. continues to lead the world with a total of 45.6 million cases and 738,883 deaths. The U.S. is averaging more than 1,400 deaths a day, although cases and hospitalizations are declining. A group of scientists who advise the Food and Drug Administration said the benefits of the Pfizer/BioNTech vaccine outweigh the risks for children between the ages of 5 and 11. The 17-0 vote in favor of the vaccine puts the U.S. one step closer to the first authorization of a shot for this age group. One member abstained. The next step is the FDA's decision. The regulator is not required to follow the recommendation of the committee, but it often does. The final regulatory stamp of approval has to come from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, which is set to meet next Tuesday and Wednesday, and the CDC director herself. India is second by cases after the U.S. at 34.2 million and has suffered 455,653 deaths. Brazil has second highest death toll at 606,646 and 21.7 million cases. In Europe, Russia has the most fatalities at 229,672 deaths, followed by the U.K. at 140,253.
3:09 p.m. Oct. 26, 2021 - Barrons.com
FDA Panel Backs Pfizer's Covid Vaccine for Children Vote comes even as committee members raise concerns about the risk of side effects.
10:49 a.m. Oct. 26, 2021 - By Ciara Linnane
FDA committee meets on COVID-19 vaccines for young children, and White House outlines new rules for travelers to U.S.The global tally of confirmed cases of the coronavirus-borne illness COVID-19 topped 244 million on Tuesday, as a U.S. Food and Drug Administration advisory committee gathered to discuss and vote on whether to recommend the Pfizer/BioNTech vaccine for children aged 5 to 11.
8:05 a.m. Oct. 26, 2021 - By Katherine Wiles
CDC adds Ukraine to its list of riskiest places to travelUkraine joins the CDC's 'Level 4' category, meaning the country is considered a 'very high' risk for travel
5:02 a.m. Oct. 26, 2021 - By Katherine Wiles
Long COVID 'affects every single aspect of a person's daily life and daily functioning,' including employment: studyA new study from researchers at Mount Sinai shows just how serious long COVID can be, and how long it can last --- even for patients who weren't hospitalized.
2:30 a.m. Oct. 26, 2021 - Barrons.com
Facebook’s Swimming in Profit as Much as It’s Mired in Controversy The longer-term issue is the company’s ability to attract young people to its platforms, given the competition from TikTok and Apple’s iMessage platform with 18-to-29-year-olds.
8:01 p.m. Oct. 25, 2021 - Barrons.com
FDA Advisors Discuss Covid Vaccines for Children Today Pfizer said last week that a child-sized dose of its Covid-19 vaccine, a third the size of the adult dose, was 90.7% effective.
7:07 p.m. Oct. 25, 2021 - MarketWatch.com
Most international travelers to U.S. will need to be vaxed under new rulesChildren under 18 and people from dozens of countries with a shortage of vaccines will be exempt from new rules that will require most travelers to the United States be vaccinated against COVID-19, the Biden administration announced Monday.
3:17 p.m. Oct. 25, 2021 - MarketWatch.com
CDC extends COVID health rules for cruise ships until mid-January Federal health officials on Monday extended for nearly three more months its rules that cruise ships must follow to sail during the pandemic.
9:38 a.m. Oct. 25, 2021 - MarketWatch.com
Companies are upping their food game to lure back skittish employeesBagels and cream cheese and deli platters won't cut it anymore. The pandemic has changed the whole gestalt of office cuisine.
9:14 a.m. Oct. 25, 2021 - By Weston Blasi
Trick-or-treating this Halloween? Here's how the CDC says to do it safelyThe CDC's tips on how to safely trick-or-treat this year include avoiding direct contact with others, staying outdoors and wearing a mask
6:17 a.m. Oct. 25, 2021 - Barrons.com
Moderna Announces Positive Data on Covid-19 Vaccine in Children Moderna said its Covid-19 vaccine was effective in children aged six to 11 in a Phase 2/3 trial. The company will submit the data to the Food and Drug Administration “in the near term.”
3:36 a.m. Oct. 25, 2021 - MarketWatch.com
Deadly bacteria found in Walmart aromatherapy spray linked to 2 U.S. deathsU.S. health officials may have solved the mystery of how four people in different states came down with a serious tropical disease even though none had traveled internationally: an aromatherapy spray imported from India.
3:14 p.m. Oct. 24, 2021 - MarketWatch.com
Florida's top health official refuses to wear mask, is told to leave meetingFlorida's top health official was asked to leave a meeting after refusing to wear a mask at the office of a state senator who told him she had a serious medical condition, officials have confirmed.
9:53 a.m. Oct. 22, 2021 - By Ciara Linnane
Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster programThere was good news for parents Friday when Pfizer said the vaccine it developed with German partner BioNTech proved 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11 in a clinical trial, using a 10 mg dose instead of the 30 mg given to adults.
6:32 a.m. Oct. 22, 2021 - Barrons.com
Pfizer and BioNTech Vaccine Is Nearly 91% Effective in Children A new study submitted by the companies shows the vaccine created a strong immune response in children between ages 5 and 11.
6:01 a.m. Oct. 22, 2021 - MarketWatch.com
Pfizer says COVID-19 vaccine is more than 90% effective in kids 5 to 11Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
4:17 a.m. Oct. 22, 2021 - Barrons.com
Mix-and-Match Booster Rollout Set to Start The director of the Centers for Disease Control and Prevention backed a series of recommendations by the CDC's Vaccine Advisory Committee.
3:01 a.m. Oct. 22, 2021 - Barrons.com
Snap’s Apple Ads Alert Is a Wake-Up Call. What to Watch Next. Snap stock plunged in late trading Thursday after the social-networking firm posted disappointing revenue growth
2:13 a.m. Oct. 22, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 242.5 million and CDC approves expanded booster programThe global tally for the coronavirus-borne illness climbed above 242.5 million on Friday, while the death toll edged above 4.93 million, according to . The U.S. continues to lead the world with a total of 45.3 million cases and 733,218 deaths. The U.S. is averaging more than 1,500 deaths a day, although cases and hospitalizations are declining. The Centers for Disease Control and Prevention on Thursday agreed to extend COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different to the one they got as primary dose, The Food and Drug Administration had already authorized such an expansion of the nation's booster campaign on Wednesday, and it was also endorsed Thursday by a CDC advisory panel. CDC Director Dr. Rochelle Walensky had the final word on who gets the extra doses. India is second by cases after the U.S. at 34.1 million and has suffered 453,042 deaths. Brazil has second highest death toll at 604,679 and 21.7 million cases. In Europe, Russia has the most fatalities at 224,369 deaths, followed by the U.K. at 139,562.
5:05 p.m. Oct. 21, 2021 - MarketWatch.com
CDC approves expanded rollout of COVID-19 boostersMillions more Americans can get a COVID-19 booster and choose a different company’s vaccine for that next shot, federal health officials said Thursday.
11:14 a.m. Oct. 21, 2021 - By Katherine Wiles
Latina Equal Pay Day spotlights the steepest wage gap — and how the pandemic has made things worseLatina workers make 57 cents for every dollar a white man earns.
10:07 a.m. Oct. 21, 2021 - By Ciara Linnane
CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trialThere was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups should be eligible for the boosters developed by Moderna and Johnson & Johnson.
7:39 a.m. Oct. 21, 2021 - Barrons.com
Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer The CDC's influential vaccines advisory committee recommended both Pfizer and Merck’s new pneumococcal vaccines for older adults, surprising analysts.
5:30 a.m. Oct. 21, 2021 - Barrons.com
Pfizer Booster Restores Efficacy to Near 96% Pfizer and BioNTech say booster shots restored the vaccine's efficacy rate to 95.6%, according to a new clinical trial.
4:45 a.m. Oct. 21, 2021 - Barrons.com
Moderna Stock Is Rising After FDA Authorization of Mix-and-Match Boosters The FDA Wednesday also gave the green light to Moderna and Johnson & Johnson's vaccines for use as booster shots.
4:43 a.m. Oct. 21, 2021 - By Ciara Linnane
Some 65,000 more men than women died of COVID-19 in the U.S. through August, and Black men are at higher risk than others, study findsAt least 65,000 more men died of COVID-19 in the U.S. through end-August than women, and Black men are at higher risk than others, according to a new study published Wednesday.
2:38 a.m. Oct. 21, 2021 - Barrons.com
Tesla Just Had a Strong Quarter. Its Valuation Is for a Very Different Business. If it were to beat estimates in every quarter next year by as much as it did during the third quarter, Tesla still would be trading at over 100 times 2022 earnings.
2:18 a.m. Oct. 21, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 242 million and FDA backs Moderna, J&J boosters and mix-and-matchThe global tally for the coronavirus-borne illness climbed above 242 million on Wednesday, while the death toll edged above 4.92 million, according to . The U.S. continues to lead the world with a total of 45.2 million cases and 731,265 deaths. The U.S. is averaging more than 1,500 deaths a day, although cases and hospitalizations are declining. U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially, The agency's decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month. But before more people roll up their sleeves, the Centers for Disease Control and Prevention will consult an expert panel Thursday before finalizing official recommendations for who should get boosters and when. India is second by cases after the U.S. at 34.1 million and has suffered 452,811 deaths. Brazil has second highest death toll at 604,228 and 21.7 million cases. In Europe, Russia has the most fatalities at 223,331 deaths, followed by the U.K. at 139,444.
2:27 p.m. Oct. 20, 2021 - MarketWatch.com
FDA backs Moderna and J&J boosters, authorizes mixing COVID vaccinesU.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
1:40 p.m. Oct. 20, 2021 - Barrons.com
FDA Authorizes Mix-and-Match Boosters The decisions seem likely to solidify the status quo in the Covid-19 vaccine market in the U.S.
11:04 a.m. Oct. 20, 2021 - By Ciara Linnane
White House unveils plan to get COVID vaccine to 5- to 11-year-olds once it's authorized, and Europe is the only region with rising cases in latest weekThe White House unveiled a plan to roll out COVID-19 vaccines to children aged 5 to 11 on Wednesday if and when shots are authorized for that patient group, in a move that is expected to assuage the concerns of parents for children now back to attending school in person.
6:46 a.m. Oct. 20, 2021 - Barrons.com
White House Lays Out Vaccine Rollout Plan for Kids The White House plans to roll out Covid-19 vaccine doses at pediatricians’ offices and primary-care sites, along with children’s hospitals, pharmacies, and school-based clinics.
6:34 a.m. Oct. 20, 2021 - MarketWatch.com
White House details plan to vaccinate children ages 5 to 11 against Covid-19Children age 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician's office, local pharmacy and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorization of the Pfizer shot for younger children in a matter of weeks.
4:48 a.m. Oct. 20, 2021 - By Jaimy Lee
White House: Children will be able to get COVID-19 shots from their pediatriciansThe White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. White House officials said there is enough vaccine to immunize all 28 million children in this age group, and kids will be able to get a shot at 25,000 pediatricians' offices, in addition to 100 children's hospitals, "tens of thousands" of pharmacies, and some school and community sites. A Food and Drug Administration advisory committee is scheduled to meet Tuesday to discuss BioNTech SE and Pfizer Inc.'s application for authorization for elementary school-aged children; it will vote on whether the vaccine is safe and effective in this age group, and then the FDA will issue its decision. The Centers for Disease Control and Prevention also has to weigh in.
Browse topics:

Filter results by

Location

Us (245)

Asia Pacific (46)

Europe (46)

Eu (36)

China (26)

Latin America (14)

Link to MarketWatch's Slice.